ECT
15
4
6
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
20%
3 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT
Amplitude Titration to Improve ECT Clinical Outcomes
Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study
CET- REM (Correlating ECT Response to EEG Markers)
Metabolomics During ElectroConvulsivoTherapy
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
The Efficiency of Simulation-Based Electroconvulsive Therapy Training
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
Effects of Erythropoietin for Cognitive Side-effects of ECT
Prediction of the Cognitive Effects of Electroconvulsive Therapy Via Machine Learning and Neuroimaging
The Effectiveness and Safety of Esketamine in Modified Electroconvulsive Therapy
Sevoflurane in Electroconvulsive Therapy
Comparison the Effects of Etomidate and Sevoflurane During Electroconvulsive Therapy
Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)
Why in Hospital - Factors Determining Time to Discharge Readiness After Arthroplasty Surgery